Eculizumab is indicated for the treatment of patients with Paroxysmal Nocturnal Hemoglobinuria and atypical Hemolytic Uremic Syndrome
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer
Prithwish has close to 28 years of experience in a Commercial role
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Mankind Pharma will have exclusive rights to register, import, market, sell and distribute sintilimab in India
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
FDC Ltd has received final approval from USFDA for the company's Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets
Subscribe To Our Newsletter & Stay Updated
